FDA pregnancy category B. It is not known whether this medication is harmful to an unborn baby.

FDA pregnancy category B. Insulin aspart and insulin aspart protamine is not expected to harm an unborn baby.

Anakinra is in the FDA pregnancy category B. This means that it is not expected to harm an unborn baby.

FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby, but HIV can be passed to your baby if you are not properly treated during pregnancy.

FDA pregnancy category B. Tranexamic acid is not expected to harm an unborn baby.

FDA pregnancy category B. Sodium oxybate is not expected to harm an unborn baby.

FDA pregnancy category B. This medication is not expected to harm an unborn baby.

FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby, unless it is used during the last 2 to 4 weeks of pregnancy.

FDA pregnancy category B. It is not known whether this medication is harmful to an unborn baby.

FDA pregnancy category B. Insulin aspart and insulin aspart protamine is not expected to harm an unborn baby.

Anakinra is in the FDA pregnancy category B. This means that it is not expected to harm an unborn baby.

FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby, but HIV can be passed to your baby if you are not properly treated during pregnancy.

FDA pregnancy category B. Tranexamic acid is not expected to harm an unborn baby.

FDA pregnancy category B. Sodium oxybate is not expected to harm an unborn baby.

FDA pregnancy category B. This medication is not expected to harm an unborn baby.

FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby, unless it is used during the last 2 to 4 weeks of pregnancy.